CLINICAL_TRIALS ClinicalTrials.gov record update

Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01835132
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:52.681534+00:00
Published At: 2015-08-25T00:00:00+00:00
Record Updated At: 2018-07-06
Results Posted At: 2015-08-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Scleritis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-07-06"
protocolSection.identificationModule.nctId: "NCT01835132"
protocolSection.identificationModule.officialTitle: "Gevokizumab Treatment for Active Scleritis By IL-1 Inhibition (GATSBY)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2015-08-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.